|
2026 Journal Article Microbiological outcomes associated with Burkholderia species in people with cystic fibrosis receiving CFTR modulator therapyRiddles, Timothy, Smith, Daniel, Reid, David W., Henderson, Daniel, Blanco, Arianne J., Moore, Vanessa, Wood, Michelle and Evans, Ieuan E. S. (2026). Microbiological outcomes associated with Burkholderia species in people with cystic fibrosis receiving CFTR modulator therapy. Journal of Cystic Fibrosis. doi: 10.1016/j.jcf.2026.03.011 |
|
2026 Journal Article Treatment outcomes and safety of clofazimine in nontuberculous mycobacterial pulmonary disease (NTM-PD)Kang, Shaun J. W., Watt, Adrian, Wilson, Malcolm R., Eather, Geoffrey W., Baird, Timothy, Evans, Ieuan E. S., Burke, Andrew J. and Thomson, Rachel M. (2026). Treatment outcomes and safety of clofazimine in nontuberculous mycobacterial pulmonary disease (NTM-PD). Mycobacteria, 2 (1) 1. doi: 10.1186/s44350-026-00012-1 |
|
2025 Journal Article Non-tuberculous mycobacterial infection in cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor: now is not the time to lower the guardEvans, Ieuan Edward Shepherd, Smith, Daniel, Henderson, Daniel, Riddles, Timothy, Masel, Philip, Moore, Vanessa, Burke, Andrew J., Thomson, Rachel M. and Reid, David W. (2025). Non-tuberculous mycobacterial infection in cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor: now is not the time to lower the guard. BMJ Open Respiratory Research, 12 (1) e003204, 1-9. doi: 10.1136/bmjresp-2025-003204 |
|
2025 Journal Article In vitro efficacy of sulbactam/durlobactam combined with β-lactam antibiotics in Australian Mycobacterium abscessus isolatesPatterson-Fahy, Kirby, Carter, Robyn, Bell, Scott C., Evans, Ieuan E. S., Burke, Andrew John and Thomson, Rachel M. (2025). In vitro efficacy of sulbactam/durlobactam combined with β-lactam antibiotics in Australian Mycobacterium abscessus isolates. Journal of Antimicrobial Chemotherapy, 81 (1) dkaf441, 1-9. doi: 10.1093/jac/dkaf441 |
|
2025 Journal Article Metabolic control of porin permeability influences antibiotic resistance in Escherichia coliCaño Muñiz, Santiago E., Trigg, Stephen, Hardo, Georgeos, Hagting, Anja, Evans, Ieuan E., Ruis, Christopher, Alsulami, Ali F., Summers, David, Crawshay-Williams, Felicity, Blundell, Tom L., Boeck, Lucas, Bakshi, Somenath and Floto, R. Andres (2025). Metabolic control of porin permeability influences antibiotic resistance in Escherichia coli. Nature Microbiology, 10 (12), 3202-3214. doi: 10.1038/s41564-025-02175-5 |
|
2025 Journal Article The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studiesEvans, Ieuan E. S., Duplancic, Christine M., Kidd, Timothy A., Ballard, Emma L., Thomson, Rachel M., Wainwright, Claire E. and Bell, Scott C. (2025). The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studies. Journal of Cystic Fibrosis, 24 (5), 903-908. doi: 10.1016/j.jcf.2025.07.002 |
|
2025 Journal Article Thoracic magnetic resonance imaging in non-tuberculous mycobacterial pulmonary disease: characteristics and potential implementationEvans, Ieuan Edward Shepherd, Baird, Timothy, Haworth, Charles S., Johnson, Christopher, Barker, Helen, Hill, Uta, Grogono, Dorothy, Eneje, Odiri, Screaton, Nicholas and Floto, Andres (2025). Thoracic magnetic resonance imaging in non-tuberculous mycobacterial pulmonary disease: characteristics and potential implementation. PLoS One, 20 (6) e0325347, 1-12. doi: 10.1371/journal.pone.0325347 |
|
2025 Journal Article Disproportionate rates of liver injury in people with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor in Queensland, AustraliaJohnson, Ellie, Riddles, Timothy, Smith, Daniel, Henderson, Daniel, Masel, Philip, Reid, David W., Moore, Vanessa and Evans, Ieuan E.S. (2025). Disproportionate rates of liver injury in people with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor in Queensland, Australia. Gastro Hep Advances, 4 (6) 100641, 1-4. doi: 10.1016/j.gastha.2025.100641 |
|
2025 Journal Article The complexities of elexacaftor/tezacaftor/ivacaftor therapeutic drug monitoring in a person with cystic fibrosis and Mycobacterium abscessus pulmonary diseaseMou, Claire Y., Henderson, Daniel J., Matson, Angela G., Herd, Karen M., Reid, David W., Riddles, Timothy, Johnson, Ellie, McWhinney, Brett, Swenson, Rebecca, Burke, Andrew and Evans, Ieuan E.S. (2025). The complexities of elexacaftor/tezacaftor/ivacaftor therapeutic drug monitoring in a person with cystic fibrosis and Mycobacterium abscessus pulmonary disease. European Clinical Respiratory Journal, 12 (1) 2458341, 1-5. doi: 10.1080/20018525.2025.2458341 |
|
2024 Journal Article Achromobacter xylosoxidans totally implantable venous access device infection in a person with cystic fibrosis: complex management considerationsEvans, Ieuan E. S., Haqqani, Haris, Smith, Daniel and Reid, David W. (2024). Achromobacter xylosoxidans totally implantable venous access device infection in a person with cystic fibrosis: complex management considerations. Respirology Case Reports, 12 (12) e70087, 1-4. doi: 10.1002/rcr2.70087 |
|
2024 Journal Article Phenotypic evaluation of rare cystic fibrosis transmembrane conductance regulator mutation combinations in people with cystic fibrosis in Queensland, AustraliaEvans, Ieuan Edward Shepherd, Wood, Michelle, Moore, Vanessa and Reid, David William (2024). Phenotypic evaluation of rare cystic fibrosis transmembrane conductance regulator mutation combinations in people with cystic fibrosis in Queensland, Australia. Journal of Clinical Medicine, 13 (20) 6210, 1-9. doi: 10.3390/jcm13206210 |
|
2024 Journal Article Mycobacterium abscessus treatment outcomes in cystic fibrosis: a single centre experienceEvans, Ieuan, Weimann, Aaron, Baird, Timothy, Haworth, Charles and Floto, Andres (2024). Mycobacterium abscessus treatment outcomes in cystic fibrosis: a single centre experience. Journal of Cystic Fibrosis, 24 (2), 364-367. doi: 10.1016/j.jcf.2024.07.016 |
|
2023 Journal Article Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmasEvans, Ieuan E. S., Kumar, Shanal, France, Megan, Smith, Daniel, Masel, Philip, Tay, George, Henderson, Daniel, Bell, Scott C. and Reid, David (2023). Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas. Respirology Case Reports, 11 (12) e01235, 1-4. doi: 10.1002/rcr2.1235 |
|
2021 Journal Article Stepwise pathogenic evolution of Mycobacterium abscessusBryant, Josephine M., Brown, Karen P., Burbaud, Sophie, Everall, Isobel, Belardinelli, Juan M., Rodriguez-Rincon, Daniela, Grogono, Dorothy M., Peterson, Chelsea M., Verma, Deepshikha, Evans, Ieuan E., Ruis, Christopher, Weimann, Aaron, Arora, Divya, Malhotra, Sony, Bannerman, Bridget, Passemar, Charlotte, Templeton, Kerra, MacGregor, Gordon, Jiwa, Kasim, Fisher, Andrew J., Blundell, Tom L., Ordway, Diane J., Jackson, Mary, Parkhill, Julian and Floto, R. Andres (2021). Stepwise pathogenic evolution of Mycobacterium abscessus. Science, 372 (6541) eabb8699, 1-13. doi: 10.1126/science.abb8699 |
|
2019 Journal Article Microbiological evaluation of UV disinfection effectiveness in a specialist cystic fibrosis clinicAllen, O., Jadkauskaite, L., Shafi, N.T., Jackson, A., Athithan, V., Chiu, Y.-D., Evans, I.E.S., Floto, R.A. and Haworth, C.S. (2019). Microbiological evaluation of UV disinfection effectiveness in a specialist cystic fibrosis clinic. Journal of Cystic Fibrosis, 18 (4), e37-e39. doi: 10.1016/j.jcf.2019.04.019 |
|
2017 Journal Article Bronchiectasis severity is an independent risk factor for vascular disease in a bronchiectasis cohortEvans, Ieuan Edward Shepherd, Bedi, Pallavi, Quinn, Tom M. and Hill, Adam T. (2017). Bronchiectasis severity is an independent risk factor for vascular disease in a bronchiectasis cohort. Chest, 151 (2), 383-388. doi: 10.1016/j.chest.2016.09.022 |
|
2013 Journal Article NSAIDs and nephrocalcinosisEvans, Ieuan, Penman, Ian, Turner, Neil and Dhaun, Neeraj (2013). NSAIDs and nephrocalcinosis. European Journal of Clinical Pharmacology, 69 (12), 2103-2104. doi: 10.1007/s00228-013-1569-6 |
